DcR Antibodies

Santa Cruz Biotechnology delivers a wide array of DcR Antibodies for advanced research in cell signaling and apoptosis. DcR Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DcR (decoy receptor) proteins regulate apoptosis by binding to death ligands, which inhibits the activation of pro-apoptotic signaling pathways. DcR protein function maintains cellular homeostasis and influences cancer development, as pathway dysregulation can lead to tumorigenesis. Research focused on DcR proteins advances understanding of potential therapeutic strategies for various diseases, including cancer and autoimmune disorders. Investigating the mechanisms of DcR proteins helps reveal fundamental aspects of cell death and survival pathways. Exploring DcR protein regulation provides valuable insights into cellular defense mechanisms and disease progression. Understanding DcR protein interactions advances knowledge of cellular communication networks. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.